Analysis by GlobalData has identified that innovative cardiovascular devices are driving diversification in the growing ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

GlobalData has named heart failure as the next disease to feel the sales-boosting power of GLP-1 drugs. The analysts expect ...

According to preliminary estimates released by GlobalData, US Light Vehicle sales grew by 2.4% year-on-year in December, to 1.51 million units.

Novartis has recently announced that its intrathecal (IT) formulation of onasemnogene abeparvovec (OAV101 IT) successfully ...

It’s become evident that a cloud-based IT portfolio brings organisations the greatest promise for providing the type of ...

In recent years, the oil and gas industry has progressed from using digital technologies for select use cases to making their ...

Virtual reality primarily has applications around training across the oil and gas value chain,' GlobalData said.

Consumer hesitation around taste remains a main challenge to successfully marketing alternative food and drink products, says GlobalData.

Based on the data, China’s domestic market saw its second consecutive month of acceleration in November.

ENB-105 is under development for the treatment of inflammatory bowel disease and immune checkpoint inhibitor colitis (ICI-Colitis). It is being developed based on eSTEM systems biology platform.

ND02 is under clinical development by HK inno.N and currently in Phase II for Glaucoma. According to GlobalData, Phase II drugs for Glaucoma have a 39% phase transition success rate (PTSR) indication ...